Cargando…
Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
Detailed information regarding lipoprotein concentrations and subfractions in cirrhotic patients before and after orthotopic liver transplantation (OLT) is lacking. Lipoprotein-Z (LP-Z) is a recently characterised abnormal, hepatotoxic free cholesterol-rich low-density lipoprotein (LDL)-like lipopro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910943/ https://www.ncbi.nlm.nih.gov/pubmed/35268313 http://dx.doi.org/10.3390/jcm11051223 |
_version_ | 1784666644209991680 |
---|---|
author | van den Berg, Eline H. Flores-Guerrero, Jose L. Gruppen, Eke G. Garcia, Erwin Connelly, Margery A. de Meijer, Vincent E. Bakker, Stephan J. L. Blokzijl, Hans Dullaart, Robin P. F. |
author_facet | van den Berg, Eline H. Flores-Guerrero, Jose L. Gruppen, Eke G. Garcia, Erwin Connelly, Margery A. de Meijer, Vincent E. Bakker, Stephan J. L. Blokzijl, Hans Dullaart, Robin P. F. |
author_sort | van den Berg, Eline H. |
collection | PubMed |
description | Detailed information regarding lipoprotein concentrations and subfractions in cirrhotic patients before and after orthotopic liver transplantation (OLT) is lacking. Lipoprotein-Z (LP-Z) is a recently characterised abnormal, hepatotoxic free cholesterol-rich low-density lipoprotein (LDL)-like lipoprotein. We determined the lipoprotein profiles, including LP-Z, in cirrhotic patients and OLT recipients and assessed the prognostic significance of LP-Z on the OLT waiting list. We performed analyses in cirrhotic transplant candidates and non-cirrhotic OLT recipients. A population-based cohort was used as reference. The setting was a University hospital. Lipoprotein particle concentrations and subfractions were measured by nuclear magnetic resonance spectroscopy. In the cirrhotic patients (N = 130), most measures of triglyceride-rich lipoproteins (TRL), LDL, and high-density lipoproteins (HDL) were much lower compared to the OLT recipients (N = 372) and controls (N = 6027) (p < 0.01). In the OLT recipients, many lipoprotein variables were modestly lower, but HDL-cholesterol, triglycerides, and TRL and HDL size were greater vs. the control population. LP-Z was measurable in 40 cirrhotic patients and 3 OLT recipients (30.8% vs. 0.8%, p < 0.001). The cirrhotic patients with measurable LP-Z levels had profoundly lower HDL-cholesterol and particle concentrations (p < 0.001), and worse Child Pugh Turcotte classifications and MELD scores. The presence of LP-Z (adjusted for age, sex, and MELD score) predicted worse survival in cirrhotic patients (HR per 1 LnSD increment: 1.11, 95%CI 1.03–1.19, p = 0.003). In conclusion, cirrhotic patients have considerably lower plasma concentrations of all major lipoprotein classes with changes in lipoprotein subfraction distribution. After OLT, these lipoprotein abnormalities are in part reversed. LP-Z is associated with cirrhosis. Its presence may translate in disturbed HDL metabolism and worse survival. |
format | Online Article Text |
id | pubmed-8910943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89109432022-03-11 Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein van den Berg, Eline H. Flores-Guerrero, Jose L. Gruppen, Eke G. Garcia, Erwin Connelly, Margery A. de Meijer, Vincent E. Bakker, Stephan J. L. Blokzijl, Hans Dullaart, Robin P. F. J Clin Med Article Detailed information regarding lipoprotein concentrations and subfractions in cirrhotic patients before and after orthotopic liver transplantation (OLT) is lacking. Lipoprotein-Z (LP-Z) is a recently characterised abnormal, hepatotoxic free cholesterol-rich low-density lipoprotein (LDL)-like lipoprotein. We determined the lipoprotein profiles, including LP-Z, in cirrhotic patients and OLT recipients and assessed the prognostic significance of LP-Z on the OLT waiting list. We performed analyses in cirrhotic transplant candidates and non-cirrhotic OLT recipients. A population-based cohort was used as reference. The setting was a University hospital. Lipoprotein particle concentrations and subfractions were measured by nuclear magnetic resonance spectroscopy. In the cirrhotic patients (N = 130), most measures of triglyceride-rich lipoproteins (TRL), LDL, and high-density lipoproteins (HDL) were much lower compared to the OLT recipients (N = 372) and controls (N = 6027) (p < 0.01). In the OLT recipients, many lipoprotein variables were modestly lower, but HDL-cholesterol, triglycerides, and TRL and HDL size were greater vs. the control population. LP-Z was measurable in 40 cirrhotic patients and 3 OLT recipients (30.8% vs. 0.8%, p < 0.001). The cirrhotic patients with measurable LP-Z levels had profoundly lower HDL-cholesterol and particle concentrations (p < 0.001), and worse Child Pugh Turcotte classifications and MELD scores. The presence of LP-Z (adjusted for age, sex, and MELD score) predicted worse survival in cirrhotic patients (HR per 1 LnSD increment: 1.11, 95%CI 1.03–1.19, p = 0.003). In conclusion, cirrhotic patients have considerably lower plasma concentrations of all major lipoprotein classes with changes in lipoprotein subfraction distribution. After OLT, these lipoprotein abnormalities are in part reversed. LP-Z is associated with cirrhosis. Its presence may translate in disturbed HDL metabolism and worse survival. MDPI 2022-02-24 /pmc/articles/PMC8910943/ /pubmed/35268313 http://dx.doi.org/10.3390/jcm11051223 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article van den Berg, Eline H. Flores-Guerrero, Jose L. Gruppen, Eke G. Garcia, Erwin Connelly, Margery A. de Meijer, Vincent E. Bakker, Stephan J. L. Blokzijl, Hans Dullaart, Robin P. F. Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title | Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title_full | Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title_fullStr | Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title_full_unstemmed | Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title_short | Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein |
title_sort | profoundly disturbed lipoproteins in cirrhotic patients: role of lipoprotein-z, a hepatotoxic ldl-like lipoprotein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910943/ https://www.ncbi.nlm.nih.gov/pubmed/35268313 http://dx.doi.org/10.3390/jcm11051223 |
work_keys_str_mv | AT vandenbergelineh profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT floresguerrerojosel profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT gruppenekeg profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT garciaerwin profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT connellymargerya profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT demeijervincente profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT bakkerstephanjl profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT blokzijlhans profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein AT dullaartrobinpf profoundlydisturbedlipoproteinsincirrhoticpatientsroleoflipoproteinzahepatotoxicldllikelipoprotein |